CAR-T Cells Persist for at Least 10 Years in Lymphoma Patients – Nature Medicine - Oncodaily

1. CAR-T Cells Persist for at Least 10 Years in Lymphoma Patients – Nature Medicine  Oncodaily
2. Decade-long persistence of CD19 CAR T cells in B cell lymphomas  Nature
3. Anas Younes: Decade-Long Persistence of CD19 CAR T Cells in B Cell Lymphomas  Oncodaily
4. Low Dose CAR T Therapy Achieved High Remission Rates  EMJ

source https://news.google.com/rss/articles/CBMiYkFVX3lxTE9uNWU0RmozRGl5YjNJNlJYeWRSbllCYWMta3p6bGxHdGV5di1uNmtXTXdlaFBFNjU4Nk02LVZhaF9zSG5CMGtJZlREMHk3WEowYk5qd0pzM1EzRUptTDgxSUh3?oc=5